Related Experiment Video
Updated: Jun 12, 2026

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
Off-pump coronary revascularization in chronic dialysis-dependent patients: early outcomes at a single institution
Giuseppe Bruschi1, Tiziano Colombo, Luca Botta
1A De Gasperis Cardiology and Cardiac Surgery Department, Niguarda Ca' Granda Hospital, Milan, Italy. giuseppe.bruschi@fastwebnet.it
Insights
Off-pump coronary artery bypass grafting (CABG) is a safe and effective myocardial revascularization strategy for end-stage renal disease patients. This approach reduces complications compared to conventional CABG with cardiopulmonary bypass (CPB).
Area of Science:
- Cardiovascular Surgery
- Nephrology
- Critical Care Medicine
Background:
- Atherosclerotic vascular disease is a major cause of death in end-stage renal disease (ESRD) patients.
- Coronary artery bypass grafting (CABG) on cardiopulmonary bypass (CPB) carries high operative risk in ESRD patients.
- Limited data exists on off-pump CABG (OPCAB) in this high-risk population.
Purpose of the Study:
- To evaluate the safety and efficacy of OPCAB in patients with ESRD.
- To compare OPCAB outcomes with conventional CABG using CPB in ESRD patients.
Main Methods:
- A retrospective analysis of 17 consecutive ESRD patients undergoing isolated OPCAB between 2000 and 2008.
- Comparison of outcomes with 23 ESRD patients who underwent conventional CABG on CPB during the same period.
- Evaluation of perioperative outcomes including mortality, morbidity, and resource utilization.
Main Results:
- OPCAB demonstrated satisfactory mortality and morbidity rates in ESRD patients.
- Compared to CPB-CABG, OPCAB patients had significantly lower rates of bleeding, transfusion, ventilation support, inotropic support, and perioperative myocardial infarction.
- OPCAB was associated with shorter ICU and hospital stays and a lower incidence of new-onset atrial fibrillation.
Conclusions:
- Avoiding CPB through OPCAB in ESRD patients is associated with acceptable postoperative complications and major adverse events.
- OPCAB is a safe and effective myocardial revascularization method for chronically dialyzed patients.
- OPCAB should be strongly considered in surgical planning for ESRD patients, with a need for multicenter randomized trials.
Introduction:
Atherosclerotic vascular disease is the leading cause of morbidity and mortality in patients with end-stage renal disease. Several authors reported that chronic dialytic patients have a high operative risk when submitted to coronary artery bypass grafting (CABG) on cardiopulmonary bypass (CPB) whereas little information exists about off-pump myocardial revascularization in these patients.
Material And Methods:
Between January 2000 and December 2008, 17 consecutive patients (12 men, mean age of 62.3 +/- 12.3 years) with end-stage renal failure maintained on chronic hemodialysis underwent isolated off-pump CABG at our center. To evaluate this approach we compared the outcomes of off-pump revascularization with those obtained in the same period in 23 patients (20 men, mean age of 64.0 +/- 9.7 years), with the same preoperative features, who underwent conventional CABG on the arrested heart using CPB.
Results:
Off-pump revascularization in end-stage renal disease patients showed a satisfactory incidence of mortality and morbidity rates. When compared with conventional CPB CABG group, off-pump patients had a lower incidence of bleeding, transfusions, ventilation support time, length of inotropic support and perioperative myocardial infarction. Also ICU and hospital stay and incidence of new-onset atrial fibrillation were lower in off-pump CABG patients.
Conclusion:
In our experience, avoidance of CPB in end-stage renal disease patients was associated with an acceptable incidence of postoperative complications and of major adverse events. Off-pump CABG is a safe and effective method of myocardial revascularization in chronically dialyzed patients that should strongly be taken in consideration when planning the surgical strategy in this selected cohort of patients, although multicentric prospective randomized controlled trials are strongly recommended.
Related Concept Videos
Hemodialysis II: Procedure and Complications
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications